A UPLC/DAD method for simultaneous determination of empagliflozin and three related substances in spiked human plasma

9Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

A simple, rapid and sensitive ultrahigh performance liquid chromatographic method was developed for the determi‑ nation of the anti‑diabetic drug: empagliflozin (EMPA) and three related substances in spiked human plasma, using dapagliflozin (DAPA) as an internal standard and tetrahydrofuran as a plasma protein precipitating agent. The chro‑ matographic separation was achieved on an Acquity “UPLC® BEH” C18 column (50 mm × 2.1 mm i.d, 1.7 µm particle size), and a mobile phase consisting of aqueous trifluoroacetic acid (0.1%, pH 2.5): acetonitrile (60:40, v/v) at a flow rate of 0.5 mL/min. Upon using the UPLC system, the run time could be reduced to less than 1.2 min, and the solvents consumption decreased to 0.36 mL of acetonitrile per run. The response was linear over a concentration range of 50–700 ng/mL and 40–200 ng/mL (r2 = 0.9994–0.9999) with lower limits of detection and quantification (LOD/LOQ) of 15/50, 11.5/40, 12/40 and 12.5/40 ng/mL for EMPA and the three related substances, respectively. Good accuracy was obtained with mean percentage recoveries ≥ 96.97% for the studied compounds. The method was validated accord‑ ing to the ICH guidelines and was found suitable for routine analysis of EMPA and its related substances in human plasma.

Cite

CITATION STYLE

APA

Mabrouk, M. M., Soliman, S. M., El‑Agizy, H. M., & Mansour, F. R. (2019). A UPLC/DAD method for simultaneous determination of empagliflozin and three related substances in spiked human plasma. BMC Chemistry, 13(1). https://doi.org/10.1186/s13065-019-0604-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free